These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 16596212)
1. Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers. Ali IU; Xiao Z; Malone W; Smith M; Conrads TP; Veenstra TD; Greenwald P; Luke BT; McLarty JW Oncol Rep; 2006 May; 15(5):1367-72. PubMed ID: 16596212 [TBL] [Abstract][Full Text] [Related]
2. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596 [TBL] [Abstract][Full Text] [Related]
3. [Serum diagnosis of head and neck squamous cell carcinoma using surface-enhanced desorption ionization mass spectrometry and artificial neural network analyses]. Cao SM; Guo X; Chen FJ; Yang AK; Chen WK; Li NW Ai Zheng; 2007 Jul; 26(7):767-70. PubMed ID: 17626756 [TBL] [Abstract][Full Text] [Related]
4. Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk. Cremona M; Calabrò E; Randi G; De Bortoli M; Mondellini P; Verri C; Sozzi G; Pierotti MA; La Vecchia C; Pastorino U; Bongarzone I Cancer; 2010 Mar; 116(5):1326-35. PubMed ID: 20087959 [TBL] [Abstract][Full Text] [Related]
5. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients. El-Aneed A; Banoub J Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443 [TBL] [Abstract][Full Text] [Related]
6. Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma. Li Y; Dang TA; Shen J; Perlaky L; Hicks J; Murray J; Meyer W; Chintagumpala M; Lau CC; Man TK Proteomics; 2006 Jun; 6(11):3426-35. PubMed ID: 16673437 [TBL] [Abstract][Full Text] [Related]
7. Possible detection of pancreatic cancer by plasma protein profiling. Honda K; Hayashida Y; Umaki T; Okusaka T; Kosuge T; Kikuchi S; Endo M; Tsuchida A; Aoki T; Itoi T; Moriyasu F; Hirohashi S; Yamada T Cancer Res; 2005 Nov; 65(22):10613-22. PubMed ID: 16288055 [TBL] [Abstract][Full Text] [Related]
8. [Preliminary study of serum proteome biomarkers of hypopharyngeal squamous cell carcinoma]. Cheng L; Zhou L; Tao L; Xiang CQ; Jia XD; Lu Y; Liao P Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1484-8. PubMed ID: 16842702 [TBL] [Abstract][Full Text] [Related]
9. Serum peptidome profiling in patients with lung cancer. Yang J; Yang SY; Hu XY; Huo SF; Shang WL; Li ZF; Ni L; Wang AY; Guo YM; Song TS; Chen-Huang Anat Rec (Hoboken); 2010 Dec; 293(12):2027-33. PubMed ID: 21082738 [TBL] [Abstract][Full Text] [Related]
10. Proteomic studies of early-stage and advanced ovarian cancer patients. Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221 [TBL] [Abstract][Full Text] [Related]
11. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry]. Zhang GQ; Du J; Pang D Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606 [TBL] [Abstract][Full Text] [Related]
12. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459 [TBL] [Abstract][Full Text] [Related]
13. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology]. Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841 [TBL] [Abstract][Full Text] [Related]
14. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics. Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929 [TBL] [Abstract][Full Text] [Related]
15. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis]. Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of gastric cancer by serum proteomic fingerprinting. Poon TC; Sung JJ; Chow SM; Ng EK; Yu AC; Chu ES; Hui AM; Leung WK Gastroenterology; 2006 May; 130(6):1858-64. PubMed ID: 16697748 [TBL] [Abstract][Full Text] [Related]
17. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639 [TBL] [Abstract][Full Text] [Related]
18. Deep proteome profiling of sera from never-smoked lung cancer patients. Au JS; Cho WC; Yip TT; Yip C; Zhu H; Leung WW; Tsui PY; Kwok DL; Kwan SS; Cheng WW; Tzang LC; Yang M; Law SC Biomed Pharmacother; 2007 Oct; 61(9):570-7. PubMed ID: 17913442 [TBL] [Abstract][Full Text] [Related]
19. [Protein profiles of serum in gastric cancer at a high-risk area by SELDI-TOF mass spectrometry]. Wang YS; Shen J; Yu JK; Zhang L; Ma JL; You WC; Pan KF Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):677-80. PubMed ID: 19175180 [TBL] [Abstract][Full Text] [Related]
20. Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry--plasma peptidomes from nasopharyngeal cancer patients for example. Chang JT; Chen LC; Wei SY; Chen YJ; Wang HM; Liao CT; Chen IH; Cheng AJ Clin Biochem; 2006 Dec; 39(12):1144-51. PubMed ID: 17014837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]